F Garrido Selected Research

F Garrido Research Topics

Disease

19	Neoplasms (Cancer) 08/2014 - 01/2000
5	Melanoma (Melanoma, Malignant) 02/2007 - 01/2000
3	Renal Cell Carcinoma (Grawitz Tumor) 04/2014 - 10/2006
2	Infections 12/2004 - 11/2002
2	Brucellosis (Malta Fever) 06/2004 - 10/2000
2	Colorectal Neoplasms (Colorectal Cancer) 05/2004 - 03/2003
2	Carcinoma (Carcinomatosis) 09/2001 - 10/2000
1	Prostatic Neoplasms (Prostate Cancer) 04/2014
1	Liver Diseases (Liver Disease) 07/2008
1	Hepatolenticular Degeneration (Wilson's Disease) 07/2008
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Carcinogenesis 01/2007
1	Acute Promyelocytic Leukemia 05/2004
1	Leukemia 05/2004
1	Fibrosarcoma 08/2001
1	Neoplasm Metastasis (Metastasis) 06/2001
1	Iron Deficiencies 07/2000
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2000

Drug/Important Bio-Agent (IBA)

8	HLA Antigens (Human Leukocyte Antigens)IBA 08/2014 - 01/2000
8	AntigensIBA 03/2012 - 06/2001
7	Peptides (Polypeptides)IBA 08/2014 - 01/2000
5	Histocompatibility Antigens Class IIBA 02/2010 - 01/2000
4	Proteins (Proteins, Gene)FDA Link 04/2014 - 03/2003
3	Monoclonal AntibodiesIBA 02/2010 - 10/2000
3	CytokinesIBA 10/2006 - 03/2000
3	HLA-A Antigens (HLA-A)IBA 03/2003 - 09/2001
3	DNA (Deoxyribonucleic Acid)IBA 08/2001 - 10/2000
2	HLA-DR Antigens (HLA-DR)IBA 02/2010 - 02/2007
2	EnzymesIBA 08/2001 - 10/2000
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 06/2001 - 10/2000
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2014
1	ParaffinIBA 02/2010
1	CopperIBA 07/2008
1	Methionine (L-Methionine)FDA Link 07/2008
1	S-Adenosylmethionine (Ademetionine)IBA 07/2008
1	MHC class II transactivator proteinIBA 02/2007
1	Histocompatibility Antigens Class IIIBA 02/2007
1	HLA-DP Antigens (HLA-DP)IBA 02/2007
1	HLA-DQ Antigens (HLA-DQ)IBA 02/2007
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2007
1	Malathion (Karbofos)FDA LinkGeneric 01/2007
1	PhysostigmineIBA 01/2007
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2007
1	Hormones (Hormone)IBA 01/2007
1	Parathion (Ethyl Parathion)IBA 01/2007
1	InterferonsIBA 10/2006
1	Interferon-gamma (Interferon, gamma)IBA 10/2006
1	Messenger RNA (mRNA)IBA 10/2006
1	Interleukin-10 (Interleukin 10)IBA 10/2006
1	ChemokinesIBA 10/2006
1	Chemokine CCL5IBA 10/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2006
1	Vascular Endothelial Growth Factor CIBA 10/2006
1	Chemokine CXCL11IBA 10/2006
1	Chemokine CXCL12IBA 10/2006
1	Chemokine CCL3IBA 10/2006
1	AntibodiesIBA 06/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2004
1	Retinoic Acid Receptor alphaIBA 05/2004
1	Complement System Proteins (Complement)IBA 11/2002
1	Rose BengalIBA 11/2002
1	Decitabine FDA Link 10/2001
1	NucleotidesIBA 09/2001
1	Biological ProductsIBA 08/2001
1	AntioxidantsIBA 08/2001
1	tert-ButylhydroperoxideIBA 08/2001
1	8-Hydroxy-2'-DeoxyguanosineIBA 08/2001
1	Malondialdehyde (Propanedial)IBA 08/2001
1	MethylcholanthreneIBA 08/2001
1	ElementsIBA 06/2001
1	MART-1 AntigenIBA 06/2001
1	Monophenol Monooxygenase (Tyrosinase)IBA 06/2001
1	ImmunosorbentsIBA 10/2000
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2000
1	Antihypertensive Agents (Antihypertensives)IBA 07/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2000
1	Terminator Codon (Termination Codon)IBA 01/2000
1	Codon (Codons)IBA 01/2000

Therapy/Procedure

7	Immunotherapy 08/2014 - 01/2000
3	Therapeutics 06/2014 - 05/2000